Mindray - Defibrillator - BeneHeart C2 (semi/auto)
Non Technical and Terms
- Initial Delivery Time - varies by country
- Pricing Incoterm - CIP
- Warranty - 18 months
- Note: Cost of installation, training and 18 months after sales service provided with CIP pricing
US$ 1,008 - $1,323 depending on country.
Supplier shall provide in-person or on-line training adequate to meet the needs of all operators. Training shall be available in English, Spanish and French, and shall be available to users within two (2) weeks of equipment delivery. (Cost of training quoted on when a Registration of Interest is received).
User Manuals: Supplier shall provide at least one (1) user manual for each device purchased. Manuals shall provide guidance on the operation of all features of the purchased device, be provided in at a printed format, and be available in English, Spanish and French.
Service Manuals: Supplier shall provide at least one (1) service manual for each device purchased. Manuals shall provide at least, equipment schematics, parts summaries, preventive maintenance requirements, and troubleshooting guidance, be accessible in printed formats, and be available in English.
Mindray (www.mindray.com) is a global provider of medical devices and solutions including patient monitoring and life support, invitro diagnostics, and medical imaging equipment. Mindray has one of the largest medical device manufacturing facilities in China.
Defibrillators deliver a high-voltage electrical shock to the heart in order to restore normal rhythm and contractile function in patients who are experiencing ventricular fibrillation (VF), ventricular tachycardia (VT), or other abnormal, shockable rhythms.
This shock is created by discharging a large capacitor which is then delivered to the heart by placing either paddles or electrodes on the patient’s chest. Audible and visual indicators alert the operator when
- the shock is charging,
- the shock is ready for delivery, and
- the shock has been delivered to the patient.
Defibrillators typically have three modes of operation including external manual defibrillation, automated external defibrillation, noninvasive pacing (e.g., synchronized cardioversion). Trained clinicians can use the external manual defibrillation mode to determine the appropriate magnitude of the delivered shock and timing of delivery.
Automated external defibrillation provides less experienced operators guidance on
how to properly defibrillate a patient. Synchronized cardioversion can correct certain arrhythmias by delivering a low energy shock when the defibrillator identifies the next R wave.
The defibrillator’s ECG monitor display can be used to verify the presence of a shockable rhythm, assess the patient’s condition, and determine the effectiveness of treatment. ECG signals can be monitored using ECG electrodes as well as the defibrillator paddles and electrodes.
Defibrillators can also be used as portable patient monitoring units and may be equipped with optional monitoring capabilities (SpO2, ETCO2, temperature, noninvasive blood pressure).